FDA Clearance Tracker · P010055-S001
PROSTALUND CORETHERM SYSTEM MICROWAVE THERMOTHERAPY FOR BPH
Last checked: Nov 20, 2026Latest source record: Jul 7, 2005 (this decision)Source: openFDAMethods & limitations
Decided
Jul 7, 2005
Approved
Time to decision
342 days
Received Jul 30, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010055-S001
- Device name
- PROSTALUND CORETHERM SYSTEM MICROWAVE THERMOTHERAPY FOR BPH
- Applicant
- Prostalund AB
- Applicant location
- Se-223 63 Lund
- Received
- Jul 30, 2004
- Decided
- Jul 7, 2005
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P010055
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR TECHNOLOGICAL MODIFICATIONS TO THE CORETHERM SYSTEM TO COMPLY WITH THE NEW EDITION OF IEC 6061-1-2 "MEDICAL ELECTRICAL EQUIPMENT - PART1: GENERAL REQUIREMENTS FOR SAFETY; ELECTROMAGNETIC COMPATIBILITY REQUIREMENTS AND TESTS" (2ND EDITION, 2001).
Source documents
Other decisions for Prostalund AB
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.